News
Denis Bilodeau, Director of Strategy and Innovation at the Montreal Heart Institute Research Centre
2013, April 29, 2013
NOTICE OF APPOINTMENT
For immediate release
Denis Bilodeau, Director of Strategy and Innovation at the Montreal Heart Institute Research Centre
Montréal, April 29, 2013 – Dr. Denis Roy, Executive Director of the Montreal Heart Institute (MHI), along with Dr. Jean-Claude Tardif, Director of the MHI Research Centre, are pleased to announce the appointment of Mr. Denis Bilodeau to the position of Director, Strategy and Innovation of the MHI Research Centre, as of April 15, 2013.
A seasoned manager, Mr. Bilodeau has to his credit 30 years' diverse expertise in the health sciences sector, both nationally and internationally. Throughout his career, he has gained vast knowledge in patient care, the pharmaceutical and services industries, the management of central laboratories, large-scale project management, and research funding. Until very recently, Mr. Bilodeau was Vice-President, Administration at Génome Québec, where he also served as Interim President and CEO. Mr. Bilodeau currently sits on the Myeloma Canada Board of Directors. He has an MBA, a graduate diploma in Institutional Administration, and Bachelor of Health Science.
Among his many accomplishments, Mr. Bilodeau notably established and oversaw the innovative Canada-wide pharmacovigilance program for clozapine, managed information systems on American and European market research, directed the BioInnova central laboratory funded by the Société générale de financement du Québec, contributed to the success of the CARTaGENE resource which now counts over 20,000 Quebec participants, and saw to the successful transfer of the National Immune Monitoring Laboratory over to Caprion.
"We are extremely pleased to have Mr. Bilodeau join our team," said Dr. Jean-Claude Tardif. "His vision, judgement, and management ethics make him an enormous asset for our group. We have entrusted him with strategic files involving the MHICC, the Beaulieu-Saucier Pharmacogenetics Centre, CEPMed and Innovacor, among others. Mr. Bilodeau's knowledge of the industry and the Quebec government system, as well as his connections with Quebec and Canadian institutional partners that are relevant to his strategic role for our platforms will foster the development of greater intersectoral collaboration and accelerate the growth and impact of the MHI Research Centre."
About the Montreal Heart Institute: www.icm-mhi.org
— 30 —
Information:
Marie-Josée Nantel
Communications Officer
Montreal Heart Institute
Phone: 514-376-3330, extension 2641
marie-josee.nantel@icm-mhi.org